Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TMEFF1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |
mRNA | ADGRE5 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | ZNF250 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | CKAP5 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
mRNA | LST1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | MSANTD3-TMEFF1 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-06 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
mRNA | ACRV1 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | HSF2 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
mRNA | STRBP | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |